Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis

Title
Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis
Authors
Keywords
-
Journal
LANCET ONCOLOGY
Volume 19, Issue 2, Pages 229-239
Publisher
Elsevier BV
Online
2018-01-18
DOI
10.1016/s1470-2045(17)30846-x

Ask authors/readers for more resources

Reprint

Contact the author

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search